Dublin, Oct. 10, 2022 (GLOBE NEWSWIRE) — The “Lyophilized Injectables Market Forecast to 2028 – Impact of COVID-19 and Global Analysis by Packaging Type, Delivery Type, Indication and End User” report has been added to from ResearchAndMarkets.com offer.
Global Lyophilized Injectables Market is expected to reach US$4,001.27 million by 2028 from US$2,719.42 million in 2021; it is expected to grow at a CAGR of 5.8% from 2022 to 2028.
Rising demand for contract research manufacturing services, increasing approvals of pharmaceuticals, and increasing demand for biologics are driving the market growth. However, high product recalls are hampering the growth of the market.
Freeze-drying is particularly popular in the pharmaceutical and diagnostic sectors. The increased quality and extended shelf life of freeze-dried injectable drugs has created growth opportunities for manufacturers to implement the process of freeze-drying in manufacturing products. Contract research and manufacturing services are in high demand, supplying lyophilized injectable drugs to deliver high quality products to end users.
Additionally, many pharmaceutical companies are refocusing on their core capabilities, such as research and development, resulting in divestitures of in-house manufacturing capabilities, which propels the demand for contract research services (CRAM) for the manufacturing. Additionally, CRAMs play a crucial role in mitigating the risk of supply shortages by providing additional sites to pharma companies with multi-site supply strategies and backup capabilities.
For example, in 2019, Samsung Biologics and GI Innovation signed a contract for immunochemotherapy. Under the agreement, Samsung Biologics provided services ranging from cell line development to the production of Phase I drug substances.
Additionally, the advantages offered by freeze-dried injectables, such as safe transit and extended pharmaceutical shelf life, have increased the adoption of the freeze-drying technique by many companies around the world.
Information based on the type of packaging
The global lyophilized injectables market, based on packaging type, is segmented into single-use vials, point-of-care reconstitution and specialty packaging. In 2021, the single-use vial segment accounted for the largest market share, while the specialty packaging segment is expected to register the highest CAGR of 6.7% during the forecast period.
Delivery Based Information Type
Based on delivery type, the global lyophilized injectables market is segmented into prefilled diluent syringes, proprietary reconstitution devices, single-step devices, and multi-step devices. The prefilled diluent syringe segment held the largest market share in 2021 and is expected to register the highest CAGR of 6.3% during the forecast period.
Information based on indications
Based on indications, the global lyophilized injectables market is segmented into metabolic and oncological conditions, infectious diseases, autoimmune diseases and other indications. The metabolic and oncology conditions segment held the largest market share in 2021 and is expected to register the highest CAGR of 6.2% during the forecast period.
End User Based Information
Based on end-user, the global lyophilized injectables market is segmented into hospitals, outpatient surgery centers, specialty clinics, and others. The hospital segment held the largest market share in 2021. However, the specialty clinic segment is expected to register the highest market CAGR of 6.3% during the forecast period.
The World Health Organization (WHO), Globocan, World Bank Data, National Health Service (NHS), National Library of Medicine (NLM) and Association for the Advancement of Medical Instrumentation are some secondary sources referred to during the preparation of the global Lyophilized Injectables market report.
Main topics covered:
2. Lyophilized Injectables Market – Key Takeaways
3. Research methodology
4. Lyophilized Injectables Market – Market Landscape
5. Lyophilized Injectables Market – Key Market Dynamics
6. Lyophilized Injectables Market – Global Analysis
7. Lyophilized Injectables Market Analysis – By Package Type
8. Lyophilized Injectables Market Analysis – By Delivery Type
9. Lyophilized Injectables Market Analysis – By Indication
10. Lyophilized Injectables Market – By End User
11. Lyophilized Injectables Market Revenue and Forecast to 2028 – Geographical Analysis
12. Impact of COVID-19 Pandemic on the Global Lyophilized Injectables Market
13. Industry Landscape of Lyophilized Injectables Market
14. Company Profiles
- Curia Global, Inc.
- Recipharm AB
- Vetter Pharma
- Jubilant HollisterStier LLC (Jubilant Pharma Limited)
- Aristopharma AG
- CordenPharma International
- Credence MedSystems, Inc.
- S-G-Biopharm Pvt-Ltd
For more information on this report, visit https://www.researchandmarkets.com/r/j5eww6